Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement
- 3 July 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (1) , 74-78
- https://doi.org/10.1161/hc2601.091386
Abstract
Background—With the best prophylactics now available, venous thromboembolism after total knee replacement remains substantial (25% to 27%). Recombinant nematode anticoagulant protein c2 (rNAPc2) is...Keywords
This publication has 9 references indexed in Scilit:
- Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2Published by Elsevier ,2001
- Prevention of Venous ThromboembolismChest, 2001
- Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty PatientsArchives of internal medicine (1960), 2000
- Efficacy and Safety of Low Molecular Weight Heparin (Ardeparin Sodium) Compared to Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement Surgery: A Double-blind, Dose-ranging StudyThrombosis and Haemostasis, 1997
- Prevention of Venous Thromboembolism after Knee ArthroplastyAnnals of Internal Medicine, 1996
- Anticoagulant repertoire of the hookworm Ancylostoma caninum.Proceedings of the National Academy of Sciences, 1996
- Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung ScanAnnals of Internal Medicine, 1983
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972